InMode - Stock Price History | INMD

Historical daily share price chart and data for InMode since 2020 adjusted for splits. The latest closing stock price for InMode as of August 03, 2020 is 33.50.
  • The all-time high InMode stock closing price was 55.84 on November 19, 2019.
  • The InMode 52-week high stock price is 58.76, which is 75.4% above the current share price.
  • The InMode 52-week low stock price is 13.06, which is 61% below the current share price.
  • The average InMode stock price for the last 52 weeks is 31.52.
InMode Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 32.1645 13.5700 55.8400 13.5700 39.2000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.071B $0.156B
InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.087B 33.45
Medtronic (MDT) Ireland $130.549B 21.20
Stryker (SYK) United States $71.817B 27.85
Boston Scientific (BSX) United States $53.175B 31.41
Lonza Group Ag (LZAGY) Switzerland $47.258B 0.00
Baxter (BAX) United States $42.098B 25.75
Terumo (TRUMY) Japan $29.607B 37.85
ResMed (RMD) United States $29.223B 46.12
EssilorLuxottica Societe Anonyme (ESLOY) France $28.452B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.013B 17.63
Sunny Optical Technology (SNPTF) China $20.336B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.809B 0.00
Bio-Rad Laboratories (BIO) United States $15.744B 71.28
Insulet (PODD) United States $12.772B 1265.31
Quidel (QDEL) United States $12.326B 65.29
Shandong Weigao Medical Polymer (SHWGF) China $12.301B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
Perrigo (PRGO) Ireland $7.465B 13.36
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $7.069B 0.00
Hill-Rom Holdings (HRC) United States $6.374B 15.82
Haemonetics (HAE) United States $4.386B 26.34
GW Pharmaceuticals (GWPH) United Kingdom $4.125B 0.00
Neogen (NEOG) United States $4.103B 68.55
ICU Medical (ICUI) United States $3.829B 27.93
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.787B 0.00
Envista Holdings (NVST) United States $3.527B 24.05
Abcam (ABCZY) $3.484B 0.00
Agios Pharmaceuticals (AGIO) United States $3.245B 0.00
NuVasive (NUVA) United States $2.857B 22.94
National Vision Holdings (EYE) United States $2.647B 45.79
TG Therapeutics (TGTX) United States $2.293B 0.00
AtriCure (ATRC) United States $1.871B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.649B 151.85
MacroGenics (MGNX) United States $1.445B 0.00
Aphria (APHA) Canada $1.413B 0.00
NanoString Technologies (NSTG) United States $1.402B 0.00
Cerus (CERS) United States $1.215B 0.00
Aurora Cannabis (ACB) Canada $1.203B 0.00
OraSure Technologies (OSUR) United States $1.189B 239.38
Vapotherm (VAPO) United States $1.128B 0.00
Meridian Bioscience (VIVO) United States $1.113B 41.92
Cardiovascular Systems (CSII) United States $1.102B 0.00
Owens & Minor (OMI) United States $1.072B 28.35
PetIQ (PETQ) United States $1.055B 30.47
Phibro Animal Health (PAHC) United States $0.946B 18.86
Quanterix (QTRX) United States $0.914B 0.00
Omeros (OMER) United States $0.698B 0.00
BioLife Solutions (BLFS) United States $0.671B 191.00
Zynex (ZYXI) United States $0.656B 57.24
Eagle Pharmaceuticals (EGRX) United States $0.653B 46.78
Surmodics (SRDX) United States $0.651B 78.39
VAREX IMAGING (VREX) United States $0.625B 15.52
LeMaitre Vascular (LMAT) United States $0.609B 37.26
Lantheus Holdings (LNTH) United States $0.529B 12.31
Viemed Healthcare (VMD) United States $0.429B 38.07
Cytosorbents (CTSO) United States $0.346B 0.00
HEXO (HEXO) $0.336B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.26
InfuSystems Holdings (INFU) United States $0.249B 137.67
Organigram Holdings (OGI) Canada $0.225B 0.00
Female Health (VERU) United States $0.199B 0.00
Chimerix (CMRX) United States $0.194B 0.00
Fonar (FONR) United States $0.160B 14.20
Bovie Medical (APYX) United States $0.159B 0.00
Exagen (XGN) United States $0.157B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Wound Management Technologies (SMTI) United States $0.135B 0.00
Liberty Health Sciences (LHSIF) Canada $0.130B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
Capricor Therapeutics (CAPR) United States $0.110B 0.00
Evolus (EOLS) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.089B 0.00
Nephros (NEPH) United States $0.074B 0.00
United-Guardian (UG) United States $0.068B 15.87
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.031B 0.00
FSD PHARMA INC (HUGE) Canada $0.029B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00